» Articles » PMID: 27458370

Mechanisms of Aβ Clearance and Degradation by Glial Cells

Overview
Specialty Geriatrics
Date 2016 Jul 27
PMID 27458370
Citations 236
Authors
Affiliations
Soon will be listed here.
Abstract

Glial cells have a variety of functions in the brain, ranging from immune defense against external and endogenous hazardous stimuli, regulation of synaptic formation, calcium homeostasis, and metabolic support for neurons. Their dysregulation can contribute to the development of neurodegenerative disorders, including Alzheimer's disease (AD). One of the most important functions of glial cells in AD is the regulation of Amyloid-β (Aβ) levels in the brain. Microglia and astrocytes have been reported to play a central role as moderators of Aβ clearance and degradation. The mechanisms of Aβ degradation by glial cells include the production of proteases, including neprilysin, the insulin degrading enzyme, and the endothelin-converting enzymes, able to hydrolyse Aβ at different cleavage sites. Besides these enzymes, other proteases have been described to have some role in Aβ elimination, such as plasminogen activators, angiotensin-converting enzyme, and matrix metalloproteinases. Other relevant mediators that are released by glial cells are extracellular chaperones, involved in the clearance of Aβ alone or in association with receptors/transporters that facilitate their exit to the blood circulation. These include apolipoproteins, α2macroglobulin, and α1-antichymotrypsin. Finally, astrocytes and microglia have an essential role in phagocytosing Aβ, in many cases via a number of receptors that are expressed on their surface. In this review, we examine all of these mechanisms, providing an update on the latest research in this field.

Citing Articles

Could immunotherapy and regulatory T cells be used therapeutically to slow the progression of Alzheimer's disease?.

Abbott V, Housden B, Houldsworth A Brain Commun. 2025; 7(2):fcaf092.

PMID: 40078868 PMC: 11896979. DOI: 10.1093/braincomms/fcaf092.


The Role of the Urea Cycle in the Alzheimer's Disease Brain.

Al-Thani N, Stewart G, Costello D J Neurochem. 2025; 169(3):e70033.

PMID: 40022483 PMC: 11871420. DOI: 10.1111/jnc.70033.


Amelioration of Astrocytic Dysfunction via AQP4/LRP1 Pathway by and Tricin in C6 Cells Exposed to Amyloid β and High-Dose Insulin and in Mice Treated with Scopolamine.

Yang S, Park S, Kim E, Bae W, Jhee K J Microbiol Biotechnol. 2025; 35:e2412026.

PMID: 40016145 PMC: 11896795. DOI: 10.4014/jmb.2412.12026.


Quantification and correlation of amyloid-β plaque load, glial activation, GABAergic interneuron numbers, and cognitive decline in the young TgF344-AD rat model of Alzheimer's disease.

Futacsi A, Rusznak K, Szarka G, Volgyi B, Wiborg O, Czeh B Front Aging Neurosci. 2025; 17:1542229.

PMID: 40013092 PMC: 11860898. DOI: 10.3389/fnagi.2025.1542229.


Molecular Mechanisms of Alzheimer's Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy.

Ahn E, Park J Cells. 2025; 14(2).

PMID: 39851517 PMC: 11764136. DOI: 10.3390/cells14020089.


References
1.
Lee S, Seo B, Koh J . Metallothionein-3 modulates the amyloid β endocytosis of astrocytes through its effects on actin polymerization. Mol Brain. 2015; 8(1):84. PMC: 4670512. DOI: 10.1186/s13041-015-0173-3. View

2.
Wilcock D, DiCarlo G, Henderson D, Jackson J, Clarke K, Ugen K . Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation. J Neurosci. 2003; 23(9):3745-51. PMC: 6742181. View

3.
Yamamoto N, Tanida M, Ono Y, Kasahara R, Fujii Y, Ohora K . Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes. Biochem Biophys Res Commun. 2014; 445(1):214-7. DOI: 10.1016/j.bbrc.2014.01.168. View

4.
Alarcon R, Fuenzalida C, Santibanez M, von Bernhardi R . Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J Biol Chem. 2005; 280(34):30406-15. DOI: 10.1074/jbc.M414686200. View

5.
Yan P, Hu X, Song H, Yin K, Bateman R, Cirrito J . Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J Biol Chem. 2006; 281(34):24566-74. DOI: 10.1074/jbc.M602440200. View